Amerika Syarikat - Inggeris - NLM (National Library of Medicine)

physicians total care, inc. - desloratadine (unii: fvf865388r) (desloratadine - unii:fvf865388r) - desloratadine 5 mg - clarinex is indicated for the relief of the nasal and non-nasal symptoms of seasonal allergic rhinitis in patients 2 years of age and older. clarinex is indicated for the relief of the nasal and non-nasal symptoms of perennial allergic rhinitis in patients 6 months of age and older. clarinex is indicated for the symptomatic relief of pruritus, reduction in the number of hives, and size of hives, in patients with chronic idiopathic urticaria 6 months of age and older. clarinex tablets 5 mg are contraindicated in patients who are hypersensitive to this medication or to any of its ingredients, or to loratadine. there is no information to indicate that abuse or dependency occurs with clarinex tablets.

Ireland - Inggeris - HPRA (Health Products Regulatory Authority)

accord healthcare ireland ltd. - desloratidine - oral solution - 0.5 milligram(s)/millilitre - other antihistamines for systemic use; desloratadine

Amerika Syarikat - Inggeris - NLM (National Library of Medicine)

a-s medication solutions - desloratadine (unii: fvf865388r) (desloratadine - unii:fvf865388r) - clarinex® is indicated for the relief of the nasal and non-nasal symptoms of seasonal allergic rhinitis in patients 2 years of age and older. clarinex is indicated for the relief of the nasal and non-nasal symptoms of perennial allergic rhinitis in patients 6 months of age and older. clarinex is indicated for the symptomatic relief of pruritus, reduction in the number of hives, and size of hives, in patients with chronic idiopathic urticaria 6 months of age and older. clarinex tablets, reditabs, and oral solution are contraindicated in patients who are hypersensitive to this medication or to any of its ingredients or to loratadine [see warnings and precautions (5.1) and adverse reactions (6.2)]. risk summary the limited available data with clarinex in pregnant women are not sufficient to inform a drug-associated risk for major birth defects and miscarriage. there are no adequate and well-controlled studies in pregnant women. desloratadine given during organogenesis to pregnant rats was not teratogenic at the

Amerika Syarikat - Inggeris - NLM (National Library of Medicine)

organon llc - desloratadine (unii: fvf865388r) (desloratadine - unii:fvf865388r) - clarinex® is indicated for the relief of the nasal and non-nasal symptoms of seasonal allergic rhinitis in patients 2 years of age and older. clarinex is indicated for the relief of the nasal and non-nasal symptoms of perennial allergic rhinitis in patients 6 months of age and older. clarinex is indicated for the symptomatic relief of pruritus, reduction in the number of hives, and size of hives, in patients with chronic idiopathic urticaria 6 months of age and older. clarinex tablets, reditabs, and oral solution are contraindicated in patients who are hypersensitive to this medication or to any of its ingredients or to loratadine [see warnings and precautions (5.1) and adverse reactions (6.2)]. risk summary the limited available data with clarinex in pregnant women are not sufficient to inform a drug-associated risk for major birth defects and miscarriage. there are no adequate and well-controlled studies in pregnant women. desloratadine given during organogenesis to pregnant rats was not teratogenic at the

Ireland - Inggeris - HPRA (Health Products Regulatory Authority)

glenmark pharmaceuticals europe limited - desloratidine - tablet - 5 milligram(s) - other antihistamines for systemic use; desloratadine

Ireland - Inggeris - HPRA (Health Products Regulatory Authority)

glenmark arzneimittel gmbh - desloratidine - tablet - 5 milligram(s) - other antihistamines for systemic use; desloratadine

Ireland - Inggeris - HPRA (Health Products Regulatory Authority)

accord healthcare ireland ltd. - desloratidine - film-coated tablet - 5 milligram(s) - other antihistamines for systemic use; desloratadine

Singapura - Inggeris - HSA (Health Sciences Authority)

organon singapore pte. ltd. - (ir layer) desloratadine, micronized; (sr layer) pseudoephedrine sulfate - tablet, delayed release - 2.5mg - (ir layer) desloratadine, micronized 2.5mg; (sr layer) pseudoephedrine sulfate 120.0mg

Malta - Inggeris - Medicines Authority

rowex ltd newtown bantry, co. cork, , ireland - desloratadine - oral solution - desloratadine 0.5 mg/ml - antihistamines for systemic use

Ireland - Inggeris - HPRA (Health Products Regulatory Authority)

rosemont pharmaceuticals ltd - desloratidine - oral solution - 0.5 mg/ml - other antihistamines for systemic use - antihistamines – h1 antagonist - it is indicated in adults, adolescents and children over the age of 1 year for the relief of symptoms associated with: allergic rhinitis, urticaria